EX-10.2



 






Exhibit 10.2




EMPLOYMENT AGREEMENT




     THIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into on January 11, 2006 (the
“Execution Date”), to be effective for all purposes as of December 16, 2005 (the
“Effective Date”), by and between General Nutrition Centers, Inc., a Delaware corporation
(the “Company”) and wholly owned subsidiary of GNC Corporation, a Delaware corporation
(“GNC”), and Robert Homler (the “Executive”).



     WHEREAS, the Company desires to employ the Executive on the terms and subject to the
conditions set forth herein and the Executive has agreed to be so employed.



     NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and
agreements set forth herein, and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound,
agree as follows:



     1. Employment of Executive; Duties.



          1.1 Title. During the Employment Period (as defined in Section 2 hereof), the
Executive shall serve as Executive Vice President and Chief Operating Officer of the Company and of
GNC. The Executive shall have the normal duties, responsibilities and authority commensurate with
such positions.




          1.2 Duties. During the Employment Period, the Executive shall do and perform all
services and acts necessary or advisable to fulfill the duties and responsibilities of the
Executive’s position and shall render such services on the terms set forth herein. In addition,
the Executive shall have such other executive and managerial powers and duties as may reasonably be
assigned to the Executive by the Board of Directors of the Company (the “Board”),
commensurate with the Executive serving as Executive Vice President and Chief Operating Officer.
The Company may adjust the duties and responsibilities of Executive as Executive Vice President and
Chief Operating Officer, notwithstanding the specific title set forth in Section 1.1 hereof, based
upon the Company’s needs from time to time. Except for sick leave, reasonable vacations and
excused leaves of absence, the Executive shall, throughout the Employment Period, devote
substantially all the Executive’s working time, attention, knowledge and skills faithfully and to
the best of the Executive’s ability, to the duties and responsibilities of the Executive’s
positions in furtherance of the business affairs and activities of the Company, and its
subsidiaries and Affiliates (as defined in Section 5.4(a) hereof) and, except where the Company
provides its written consent otherwise, shall maintain the Executive’s principal residence within
75 miles of the principal office of the Company as of the Effective Date. The Executive shall at
all times be subject to, comply with, observe and carry out (a) the Company’s rules, regulations,
policies and codes of ethics and/or conduct applicable to its employees generally and in effect
from time to time and (b) such rules, regulations, policies, codes of ethics and/or conduct,
directions and restrictions as the Board may from time to time reasonably establish or approve for
senior executive officers of the Company.




 









 








     2. Term of Employment.



          2.1 Employment Period. The employment of the Executive hereunder shall continue until
December 31, 2007 (the “Initial Employment Period”), unless terminated earlier in
accordance with the provisions of Section 4 of this Agreement.




          2.2 Extension. Unless terminated earlier in accordance with the provisions of Section
4 of this Agreement, the employment of the Executive hereunder shall continue after the end of the
Initial Employment Period for additional one (1)-year periods (each an “Extension Period”
and, together with the Initial Employment Period, the “Employment Period”), unless the
Company or the Executive notifies the other in writing not less than one (1) year prior to the end
of the Initial Employment Period, or the end of the applicable Extension Period, of its or the
Executive’s election, in its or the Executive’s sole discretion, not to extend the Employment
Period.




     3. Compensation and General Benefits.



          3.1 Base Salary.




               (a) During the Employment Period, and retroactively to December 4, 2005, the Company agrees to
pay to the Executive an annual base salary in an amount equal to $350,000 (such base salary, as may
be adjusted from time to time pursuant to Section 3.1(b), is referred to herein as the “Base
Salary”). The Executive’s Base Salary, less amounts required to be withheld under applicable
law, shall be payable in equal installments in accordance with the Company’s normal payroll
practices and procedures in effect from time to time for the payment of salaries to officers of the
Company, but in no event less frequently than monthly.



               (b) The Board or the Compensation Committee established by the Board (the “Compensation
Committee”) shall review the Executive’s performance on an annual basis and, based on such
review, may change the Base Salary, as it, acting in its sole discretion, shall determine to be
reasonable and appropriate.



          3.2 Bonus. With respect to the 2005 calendar year and with respect to each calendar
year that commences during the Employment Period, the Executive shall be eligible to receive from
the Company an annual performance bonus (the “Annual Bonus”) on a basis and in an amount to
be determined by the Board or the Compensation Committee in the exercise of its sole discretion for
the applicable year. Any Annual Bonus earned shall be payable in full as soon as reasonably
practicable following the determination thereof, but in no event later than May 15 of the following
year, and in accordance with the Company’s normal payroll practices and procedures. Except as
otherwise expressly provided in Section 4 hereof, any Annual Bonus (or portion thereof) payable
under this Section 3.2 shall not be payable unless the Executive is employed by the Company on the
last day of the period to which such Annual Bonus relates.




          3.3 Expenses. During the Employment Period, in addition to any amounts to which the
Executive may be entitled pursuant to the other provisions of this Section 3.3 or elsewhere herein,
the Executive shall be entitled to receive reimbursement from




2









 







the Company for all reasonable and necessary expenses incurred by the Executive in performing
the Executive’s duties hereunder on behalf of the Company, subject to, and consistent with, the
Company’s policies for expense payment and reimbursement, in effect from time to time.




          3.4 Fringe Benefits. During the Employment Period, in addition to any amounts to
which the Executive may be entitled pursuant to the other provisions of this Section 3 or elsewhere
herein, the Executive shall be entitled to participate in, and to receive benefits under, (a) any
benefit plans, arrangements or policies made available by the Company to its employees generally,
subject to and on a basis consistent with the terms, conditions and overall administration of each
such plan, arrangement or policy, and (b) without limiting the foregoing, the benefits set forth on
Exhibit B attached hereto.




          3.5 Stock Options. During the Employment Period and subject to the approval of the
Compensation Committee and the GNC Compensation Committee, or other Administrator of the Plan (as
defined therein), the Executive shall be eligible to participate in and be granted awards under the
General Nutrition Centers Holding Company (presently known as GNC Corporation) 2003 Omnibus Stock
Incentive Plan (the “Plan”). In the event of a Change of Control (as defined in Exhibit A
attached hereto), all of the Executive’s stock options granted pursuant to the Plan shall vest in
full and become immediately exercisable.




     4. Termination.



          4.1 General. The employment of the Executive hereunder (and the Employment Period)
shall terminate as provided in Section 2 hereof, unless earlier terminated in accordance with the
provisions of this Section 4.




          4.2 Death or Disability of the Executive.




               (a) The employment of the Executive hereunder (and the Employment Period) shall terminate upon
(i) the death of the Executive, and (ii) at the option of the Company, upon not less than fifteen
(15) days’ prior written notice to the Executive or the Executive’s personal representative or
guardian, if the Executive suffers a “Total Disability” (as defined in Section 4.2(b) hereof).
Upon termination for death or Total Disability, subject to reduction by any benefits paid or
payable to the Executive, the Executive’s beneficiaries or estate under any Company-sponsored
disability benefit plan program or policy for the period following such date of termination;
provided, however, that no such reduction shall be made for any benefits paid upon
the Executive’s death under the Company’s life insurance policy, (A) the Company shall pay to the
Executive, guardian or personal representative, as the case may be, the Executive’s current Base
Salary for the remainder of the Employment Period in effect immediately prior to the date of
termination, and (B) subject further to the sole discretion of the Board or the Compensation
Committee, the Company may also pay to the Executive, guardian or personal representative, as the
case may be, a prorated share of the Annual Bonus pursuant to Section 3.2 hereof (based on the
period of actual employment) that the Executive would have been entitled to had the Executive
worked the full year during which the termination occurred, provided that bonus targets are met for
the year of such termination. Any bonus shall be payable as soon as reasonably practicable
following the determination thereof, but in no event later than



3









 




May 15 of the following year, and in accordance with the Company’s normal payroll practices
and procedures.




               (b) Subject to the last sentence of this Section 4.2(b), for purposes of this Agreement,
“Total Disability” shall mean (i) if the Executive is subject to a legal decree of
incompetency (the date of such decree being deemed the date on which such disability occurred),
(ii) the written determination by a physician selected by the Company that, because of a medically
determinable disease, injury or other physical or mental disability, the Executive is unable
substantially to perform, with or without reasonable accommodation, the material duties of the
Executive required hereby, and that such disability has lasted for ninety (90) consecutive days or
any one hundred twenty (120) days during the immediately preceding twelve (12)-month period or is,
as of the date of determination, reasonably expected to last six (6) months or longer after the
date of determination, in each case based upon medically available reliable information or (iii)
Executive’s qualifying for benefits under the Company’s long-term disability coverage, if any. In
conjunction with determining mental and/or physical disability for purposes of this Agreement, the
Executive hereby consents to (x) any examinations that the Board or the Compensation Committee
determines are relevant to a determination of whether the Executive is mentally and/or physically
disabled or are required by the Company physician, (y) furnish such medical information as may be
reasonably requested and (z) waive any applicable physician patient privilege that may arise
because of such examination. Notwithstanding anything to the contrary in this Section 4.2(b),
Total Disability shall have the definition of “Disabled” contained in Section 409A of the Internal
Revenue Code of 1986, as amended (the “Code”), in any instance in which amounts are paid
under this Agreement as a result of Executive’s Total Disability and such amounts are treated as
deferred compensation under Section 409A of the Code.



               (c) With respect to outstanding stock options and other equity-based awards held by the
Executive as of the date of termination pursuant to this Section 4.2, (i) any such options that are
not vested or exercisable as of such date of termination shall immediately expire and any such
equity-based awards that are not vested as of such date of termination shall immediately be
forfeited, and (ii) any such options that are vested and exercisable as of such date of termination
shall expire immediately following the expiration of the one hundred eighty (180)-day period
following such date of termination.



               (d) With respect to any shares of Common Stock of GNC (the “Common Stock”) held by the
Executive that are vested as of the date of termination pursuant to this Section 4.2 (or issued
pursuant to the exercise of options following such date of termination pursuant to Section 4.2(c)
hereof), for the two hundred seventy (270)-day period following such date of termination, the
Company (or its designee) shall have the right to purchase from the Executive or the Executive’s
beneficiary, as applicable, and the Executive or the Executive’s beneficiary hereby agrees to sell
any or all such shares to the Company (or the Company’s designee) for an amount equal to the
product of (i) the per share current fair market value of a share of Common Stock (as determined by
the Board in good faith) and (ii) the number of shares so purchased.



4









 





          4.3 Termination by the Company Without Cause or Resignation by the Executive For Good
Reason.




               (a) The Company may terminate the Executive’s employment without “Cause” (as defined in
Section 4.3(g)), and thereby terminate the Executive’s employment (and the Employment Period) under
this Agreement at any time with no requirement for notice to the Executive.



               (b) The Executive may resign, and thereby terminate the Executive’s employment (and the
Employment Period), at any time for “Good Reason” (as defined in Section 4.3(f) hereof), upon not
less than sixty (60) days’ prior written notice to the Company specifying in reasonable detail the
reason therefore; provided, however, that the Company shall have a reasonable
opportunity to cure any such Good Reason (to the extent possible) within thirty (30) days after the
Company’s receipt of such notice; and provided further that, if the Company is not seeking
to cure, the Company shall not be obligated to allow the Executive to continue working during such
period and may, in its sole discretion, accelerate such termination of employment (and the
Employment Period) to any date during such period.




               (i) Executive may not terminate employment under this Agreement for Good Reason
regarding any of the Company’s acts or omissions of which Executive had actual
notice for 60 days or more prior to giving notice of termination for Good Reason.




               (ii) A determination of whether the Executive legitimately has Good Reason for
termination of the Executive’s employment under this Agreement, and of whether the
Company has effectively cured and thus eliminated the grounds for such Good Reason,
shall be made only by the President of the Company, within the President’s sole
judgment and discretion, acting in good faith after having met with the Company’s
Vice President of Human Resources.



               (c) In the event the Executive’s employment is terminated pursuant to this Section 4.3, then,
subject to Section 4.3(d) hereof, the following provisions shall apply:




               (i) The Company shall continue to pay the Executive the Base Salary to which
the Executive would have been entitled pursuant to Section 3.1 hereof (at the Base
Salary rate during the year of termination) had the Executive remained in the employ
of the Company until the expiration of the Employment Period in effect immediately
prior to the date of termination, with all such amounts payable in accordance with
the Company’s normal payroll practices and procedures in the same manner and at the
same time as though the Executive remained employed by the Company.




               (ii) If such termination occurs upon or within six (6) months following a
Change of Control (as defined in Exhibit A attached hereto), the Company shall
continue to pay the Executive the Base Salary to which the



5









 








Executive would have been entitled pursuant to Section 3.1 hereof (at the Base
Salary rate during the year of termination) for the greater of (A) the period set
forth in Section 4.3(c)(i) hereof or (B) a two (2)-year period following such date
of termination, with all such amounts payable in accordance with the Company’s
normal payroll practices and procedures in the same manner and at the same time as
though the Executive remained employed by the Company.




               (iii) In the event the Executive’s employment is terminated pursuant to this
Section 4.3 without Cause, and if the Company has previously effected reductions in
the Executive’s Base Salary and the base salary of all executives at the same level
as the Executive, which reductions were substantially similar, then the Base Salary
rate for purposes of Section 4.3(c)(i) or (ii) hereof shall be the Base Salary rate
in effect immediately prior to such reductions.




               (iv) Subject to the sole discretion of the Board or the Compensation Committee,
the Company may pay to the Executive a prorated share of the Annual Bonus pursuant
to Section 3.2 hereof (based on the period of actual employment) that the Executive
would have been entitled to had the Executive worked the full year during which the
termination occurred, provided that bonus targets are met for the year of such
termination. The bonus shall be payable as soon as reasonably practicable following
the determination thereof, but in no event later than May 15 of the following year,
and in accordance with the Company’s normal payroll practices and procedures.




               (v) If the Executive elects continuation coverage (with respect to the
Executive’s coverage and/or any eligible dependent coverage)
under the
Consolidated Omnibus Budget Reconciliation Act of 1986 (“COBRA Continuation
Coverage”) with respect to the Company’s group health insurance plan, the
Executive shall be responsible for payment of the monthly cost of COBRA Continuation
Coverage. Unless prohibited by law, the Company shall reimburse the Executive for
any portion of the monthly cost of COBRA Continuation Coverage that exceeds the
amount of the monthly health insurance premium (with respect to the Executive’s
coverage and/or any eligible dependent coverage) payable by the Executive
immediately prior to the date of Executive’s termination, such reimbursements to
continue (A) through the expiration of the Employment Period in effect immediately
prior to the date of termination, or, (B) in the event that Executive’s Base Salary
is being paid pursuant to Section 4.3(c)(ii), for the period set forth therein. The
Company shall pay the reimbursements on a monthly basis in accordance with the
Company’s normal payroll practices and procedures.




               (vi) With respect to outstanding options and other equity-based awards held by
the Executive as of the date of termination pursuant to this Section 4.3, (A) any
such options that are not vested or exercisable as of such date of termination shall
immediately expire and any such equity-based awards that are not vested as of such
date of termination shall immediately be



6









 








forfeited, and (B) any such options that are vested and exercisable as of such
date of termination shall expire immediately following the expiration of the ninety
(90)-day period following such date of termination.




               (vii) With respect to any shares of Common Stock held by the Executive that are
vested as of the date of termination pursuant to this Section 4.3 (or issued
pursuant to the exercise of options following such date of termination pursuant to
Section 4.3(c)(vi) hereof), for the one hundred eighty (180)-day period following
such date of termination, the Company (or its designee) shall have the right to
purchase from the Executive and the Executive hereby agrees to sell any or all such
 shares to the Company (or the Company’s designee) for an amount equal to the product
of (A) the per share current fair market value of a share of Common Stock (as
determined by the Board in good faith) and (B) the number of shares so purchased.




               (viii) The Executive shall continue to be entitled to the perquisites available
to the Executive immediately preceding the Executive’s date of termination as
provided in the Perquisite Policy for Senior Executives (as such policy may be
amended by the Board from time to time), in each case (A) through the expiration of
the Employment Period in effect immediately prior to the date of termination, or,
(B) in the event that Executive’s Base Salary is being paid pursuant to Section
4.3(c)(ii), for the period set forth therein.



               (d) As a condition precedent to the Executive’s right to receive the benefits set forth in
Section 4.3(c) hereof, the Executive agrees to execute a release of the Company and its respective
Affiliates, officers, directors, stockholders, employees, agents, insurers, representatives and
successors from and against any and all claims that the Executive may have against any such Person
(as defined in Section 5.4(f) hereof) relating to the Executive’s employment by the Company and the
termination thereof, such release to be in form and substance reasonably satisfactory to the
Company.



               (e) Anything in this Agreement to the contrary notwithstanding, if it shall be determined that
any payment, vesting, distribution or transfer by the Company or any successor, or any Affiliate of
the foregoing or by any other Person or that any other event occurring with respect to the
Executive and the Company for the Executive’s benefit, whether paid or payable or distributed or
distributable under the terms of this Agreement or otherwise (including under any employee benefit
plan) (a “Payment”) would be subject to or result in the imposition of the excise tax
imposed by Section 4999 of the Code (and any regulations or guidance promulgated or issued
thereunder, any successor provision, and any similar provision of state or local income tax law)
(collectively, the “Excise Tax”), then the amount of the Payment shall be reduced to the
highest amount that may be paid by the Company or other entity without subjecting any such Payment
to the Excise Tax (the “Payment Reduction”). The Executive shall have the right to
designate those payments or benefits that shall be reduced or eliminated under the Payment
Reduction to avoid the imposition of the Excise Tax, subject to the confirmation of the Accounting
Firm (as defined herein) with respect to the intended effect thereof. Notwithstanding the
foregoing, the Payment Reduction shall not



7









 




apply if the Executive would, on a net after-tax basis, receive less compensation than if the
Payment were not so reduced.





               (i) Subject to the provisions of Section 4.3(e)(ii), all determinations
required to be made under this Section 4.3(e), including whether and when a Payment
is subject to Section 4999 and the assumptions to be utilized in arriving at such
determination and in determining an appropriate Payment Reduction, shall be made by
PricewaterhouseCoopers LLP, or any other nationally recognized accounting firm that
shall be the Company’s outside auditors at the time of such determination (the
“Accounting Firm”), which Accounting Firm shall provide detailed supporting
calculations to the Executive and the Company within fifteen (15) business days of
the receipt of notice from the Company or the Executive that there will be a Payment
that the Person giving notice believes may be subject to the Excise Tax. All fees
and expenses of the Accounting Firm shall be borne by the Company. Any
determination by the Accounting Firm shall be binding upon the Company and the
Executive in determining whether a Payment Reduction is required and the amount
thereof (subject to Sections 4.3(e)(ii) and (iii)), in the absence of material
mathematical or legal error.




               (ii) As a result of uncertainty in the application of Section 4999 that may
exist at the time of the initial determination by the Accounting Firm, it may be
possible that in making the calculations required to be made hereunder, the
Accounting Firm shall determine that a Payment Reduction need not be made that
properly should be made (an “Overpayment”) or that a Payment Reduction not
properly needed to be made should be made (an “Underpayment”). If, within
seventy-five (75) days after the Accounting Firm’s initial determination under
Section 4.3(e)(i), the Accounting Firm shall determine that an Overpayment was made,
any such Overpayment shall be treated for all purposes, to the extent practicable
and subject to applicable law, as a loan to the Executive with interest at the
applicable Federal rate provided for in Section 1274(d) of the Code and shall be
repaid by the Executive to the Company within thirty-five (35) days after the
Executive receives notice of the Accounting Firm’s determination; provided,
however, that the amount to be repaid by the Executive to the Company either
as a loan or otherwise as a lump sum payment (where a loan is not practicable or
permitted by law) shall be reduced to the extent that any portion of the Overpayment
to be repaid will not be offset by a corresponding reduction in tax by reason of
such repayment of the Overpayment. If the Accounting Firm shall determine that an
Underpayment was made, any such Underpayment shall be due and payable by the Company
to the Executive within thirty-five (35) days after the Company receives notice of
the Accounting Firm’s determination.




               (iii) The Executive shall give written notice to the Company of any claim by
the Internal Revenue Service that, if successful, would require the payment by the
Executive of an Excise Tax, such notice to be provided within fifteen (15) days
after the Executive shall have received written



8









 








notice of such claim. The Executive shall cooperate with the Company in
determining whether to contest or pay such claim and shall not pay such claim
without the written consent of the Company, which shall not be unreasonably
withheld, conditioned or delayed.




               (iv) This Section 4.3(e) shall remain in full force and effect following the
termination of the Executive’s employment for any reason until the expiration of the
statute of limitations on the assessment of taxes applicable to the Executive for
all periods in which the Executive may incur a liability for taxes (including Excise
Taxes), interest or penalties arising out of the operation of this Agreement.



               (f) For purposes of this Agreement, the Executive would be entitled to terminate the
Executive’s employment for “Good Reason” if without the Executive’s prior written consent:




               (i) the Company fails to comply with any material obligation imposed by this
Agreement;




               (ii) the Company changes the Executive’s position from that of Executive Vice
President and Chief Operating Officer other than to a more senior position;
provided, however, that a change in the Executive’s duties or
responsibilities without a change in the Executive’s position as Executive Vice
President and Chief Operating Officer shall not constitute Good Reason;




               (iii) the Company effects a reduction in the Executive’s Base Salary, unless
all executives at the same level as the Executive receive a substantially similar
reduction in base salary; or




               (iv) the Company requires the Executive to be based (excluding regular travel
responsibilities) at any office or location more than 75 miles from the principal
office of the Company.



               (g) For purposes of this Agreement, “Cause” means the occurrence of any one or more of
the following events, and the Company shall have the sole discretion to determine the existence of
Cause:




               (i) a failure by the Executive to comply with any obligation under this
Agreement;




               (ii) the Executive’s being indicted for (A) any felony or (B) any misdemeanor
that causes or is likely to cause harm or embarrassment to the Company or any of its
Affiliates, in the reasonable judgment of the Board;




               (iii) theft, embezzlement or fraud by the Executive in connection with the
performance of the Executive’s duties hereunder;



9









 






               (iv) the Executive’s engaging in any activity that gives rise to a material
conflict with the Company or any of its Affiliates;




               (v) the misappropriation by the Executive of any material business opportunity
of the Company or any of its Affiliates;




               (vi) any failure to comply with, observe or carry out the Company’s rules,
regulations, policies and codes of ethics and/or conduct applicable to its employees
generally and in effect from time to time, including (without limitation) those
regarding conflicts, potential conflicts of interest or the appearance of a conflict
of interest




               (vii) any failure to comply with, observe or carry out the rules, regulations,
policies, directions, codes of ethics and/or conduct and restrictions established or
approved by the Board from time to time for senior executive officers of the
Company, including (without limitation) those regarding conflicts, potential
conflicts of interest or the appearance of a conflict of interest;




               (viii) substance abuse or use of illegal drugs that, in the reasonable judgment
of the Board, (A) impairs the Executive’s performance of the Executive’s duties
hereunder or (B) causes or is likely to cause harm or embarrassment to the Company
or any of its Affiliates; and




               (ix) engagement in conduct that Executive knows or should know is injurious to
the Company or any of its Affiliates.



          4.4 Termination For Cause, Voluntary Resignation Other Than For Good Reason or Election
Not to Extend the Employment Period.




               (a) (i) The Company may, upon action of the Board, terminate the employment of the Executive
(and the Employment Period) at any time for “Cause,” (ii) the Executive may voluntarily resign
other than for Good Reason and thereby terminate the Executive’s employment (and the Employment
Period) under this Agreement at any time upon not less than thirty (30)-days’ prior written notice
or (iii) either the Company or the Executive may elect not to extend or further extend the
Employment Period pursuant to Section 2.2 hereof.



               (b) The following provisions shall apply upon termination by the Company for Cause, by the
Executive as the result of resignation for other than for Good Reason, or by the Company or the
Executive at the end of the Employment Period as the result of an election not to extend or further
extend the Employment Period:




               (i) The Executive shall be entitled to receive all amounts of earned but unpaid
Base Salary and benefits accrued through the date of such termination. Except as
provided below, all other rights of the Executive (and all obligations of the
Company) hereunder shall terminate as of the date of such termination.



10









 







               (ii) With respect to outstanding options and other equity-based awards held by
the Executive as of the date of termination pursuant to this Section 4.4, (A) any
such options that are not vested or exercisable as of such date of termination shall
immediately expire and any such equity-based awards that are not vested as of such
date of termination shall immediately be forfeited, and (B) any such options that
are vested and exercisable as of such date of termination shall expire immediately
following the expiration of the ninety (90)-day period following such date of
termination.




               (iii) With respect to any shares of Common Stock held by the Executive that are
vested as of the date of termination pursuant to this Section 4.4 (or issued
pursuant to the exercise of options following such date of termination pursuant to
Section 4.4(b)(ii) hereof), for the one hundred eighty (180)-day period following
such date of termination, the Company (or its designee) shall have the right to
purchase from the Executive and the Executive hereby agrees to sell any or all such
shares to the Company (or the Company’s designee) for an amount equal to the product
of (A) the per share current fair market value of a share of Common Stock (as
determined by the Board in good faith) and (B) the number of shares so purchased.



               (c) Before the Company may terminate the Executive for Cause pursuant to Section 4.4(a)(i),
the Board shall deliver to the Executive a written notice of the Company’s intent to terminate the
Executive for Cause, and the Executive shall have been given a reasonable opportunity to cure any
such acts or omissions (which are susceptible of cure as reasonably determined by the Board) within
thirty (30) days after the Executive’s receipt of such notice.



          4.5 Resignation from Officer Positions. Upon the termination of the Executive’s
employment for any reason (unless otherwise agreed in writing by the Company and the Executive),
the Executive will be deemed to have resigned, without any further action by the Executive, from
any and all officer, director and/or director positions that the Executive, immediately prior to
such termination, (a) held with the Company or any of its Affiliates and (b) held with any other
entities at the direction of, or as a result of the Executive’s affiliation with, the Company or
any of its Affiliates. If for any reason this Section 4.5 is deemed to be insufficient to
effectuate such resignations, then Executive will, upon the Company’s request, execute any
documents or instruments that the Company may deem necessary or desirable to effectuate such
resignations. In addition, the Executive hereby designates the Secretary or any Assistant
Secretary of the Company and of any Affiliate to execute any such documents or instruments as the
Executive’s attorney-in-fact to effectuate such resignations if execution by the Secretary or any
Assistant Secretary of the Company or Affiliate is deemed by the Company or the Affiliate to be a
more expedient means to effectuate such resignation or resignations.




11









 








     5. Confidentiality, Work Product and Non-Competition and Non-Solicitation.



          5.1 Confidentiality.




               (a) In connection with the Executive’s employment with the Company, the Company promises to
provide the Executive with access to “Confidential Information” (as defined in Section 5.4(d)
hereof) in support of the Executive’s employment duties. The Executive recognizes that the
Company’s business interests require a confidential relationship between the Company and the
Executive and the fullest practical protection and confidential treatment of all Confidential
Information. At all times, both during and after the Employment Period, the Executive shall not
directly or indirectly: (i) appropriate, use or disclose, or otherwise “Misappropriate” (as
defined in Section 5.4(e) hereof), any Confidential Information, including, without limitation,
originals or copies of any Confidential Information, in any media or format, except for the
Company’s benefit within the course and scope of the Executive’s employment or with the prior
written consent of the Chief Executive Officer of the Company (the “Chief Executive
Officer”); or (ii) take or encourage any action that would circumvent, interfere with or
otherwise diminish the value or benefit of the Confidential Information to any of the Company
Parties (as defined in Section 5.4(b) hereof).



               (b) All Confidential Information is the property of the respective Company Parties, the
appropriation, use and/or disclosure of which is governed and restricted by this Agreement.



               (c) The Executive acknowledges and agrees that:




               (i) the Executive occupies a unique position within the Company, and the
Executive is and will be intimately involved in the development and/or
implementation of Confidential Information;




               (ii) in the event the Executive breaches this Section 5.1 with respect to any
Confidential Information, such breach shall be deemed to be a Misappropriation of
such Confidential Information; and




               (iii) any Misappropriation of Confidential Information will result in immediate
and irreparable harm to the Company.



               (d) Upon receipt of any formal or informal request seeking the Executive’s direct or indirect
disclosure or production of any Confidential Information to any Person, the Executive shall
promptly and timely notify the Company and provide a description and, if applicable, hand deliver a
copy of such request to the Company. The Executive irrevocably nominates and appoints the Company
as the Executive’s true and lawful attorney-in-fact to act in the Executive’s name, place and stead
to perform any act that the Executive might perform to defend and protect against any disclosure of
Confidential Information.



               (e) At any time the Company may request, during or after the Employment Period, the Executive
shall deliver to the Company all originals and copies of Confidential Information and other Company
property within the Executive’s possession,



12









 




custody or control, regardless of form or format, including, without limitation any
Confidential Information produced by the Executive. Both during and after the Employment Period,
the Company shall have the right of reasonable access to review, inspect, copy and/or confiscate
any Confidential Information within the Executive’s possession, custody or control.




               (f) During the Employment Period, the Executive represents and agrees that the Executive will
not use or disclose any confidential or proprietary information or trade secrets of others,
including but not limited to former employers, and that the Executive will not bring onto the
premises of the Company or access such confidential or proprietary information or trade secrets of
such others, unless consented to in writing by said others, and then only with the prior written
authorization of the Company.



          5.2 Work Product/Intellectual Property.




               (a) Assignment. The Executive hereby assigns to the Company all right, title and
interest to all “Work Product” (as defined in Section 5.4(h) hereof) that relates to any of the
Company Parties’ actual or anticipated business, research and development or existing or future
products or services, or that is conceived, reduced to practice, developed or made using any
equipment, supplies, facilities, assets, information or resources of any of the Company Parties
(including, without limitation, any intellectual property rights).



               (b) Disclosure. The Executive shall promptly disclose Work Product to the Chief
Executive Officer and perform all actions reasonably requested by the Company (whether during or
after the Employment Period) to establish and confirm the ownership and proprietary interest of any
of the Company Parties in any Work Product (including, without limitation, the execution of
assignments, consents, powers of attorney, applications and other instruments). The Executive
shall not file any patent or copyright applications related to any Work Product except with the
written consent of the Chief Executive Officer.



          5.3 Non-Competition and Non-Solicitation.




               (a) In consideration of the Confidential Information being provided to the Executive as stated
in Section 5.1 hereof, and other good and valuable new consideration as stated in this Agreement,
including, without limitation, employment and/or continued employment with the Company, and the
business relationships, Company goodwill, work experience, customer relationships and other fruits
of employment that the Executive will obtain, use and develop under this Agreement, the Executive
agrees to the restrictive covenants stated in this Section 5.3.



               (b) During the Employment Period and until the end of the Restricted Period (as defined in
Section 5.4(g) hereof), the Executive agrees that the Executive will not, directly or indirectly,
on the Executive’s own behalf or on the behalf of any other Person, within the United States of
America or in any other country or territory in which the businesses of the Company are conducted:




               (i) engage in a Competing Business, including, without limitation, by owning,
managing, operating, controlling, being employed by,



13









 







providing services as a consultant or independent contractor to or
participating in the ownership, management, operation or control of any Competing
Business;




               (ii) induce or attempt to induce any customer, vendor, supplier, licensor or
other Person in a business relationship with any Company Party, for which the
Executive or employees working under the Executive’s supervision had any direct or
indirect responsibility during the Employment Period, (A) to do business with a
Competing Business, or (B) to cease, restrict, terminate or otherwise reduce
business with the Company for the benefit of a Competing Business, regardless of
whether the Executive initiates contact; or




               (iii) (A) solicit, recruit, persuade, influence, or induce, or attempt to
solicit, recruit, persuade, influence, or induce anyone employed or otherwise
retained by any of the Company Parties (including any independent contractor or
consultant), to cease or leave their employment or contractual or consulting
relationship with any Company Party, regardless of whether the Executive initiates
contact for such purposes, or (B) hire, employ or otherwise attempt to establish,
for any Person, any employment, agency, consulting, independent contractor or other
business relationship with any Person who is or was employed or otherwise retained
by any of the Company Parties (including any independent contractor or consultant).



               (c) The parties hereto acknowledge and agree that, notwithstanding anything in Section
5.3(b)(i) hereof, (i) the Executive may own or hold, solely as passive investments, securities of
Persons engaged in any business that would otherwise be included in Section 5.3(b)(i), as long as
with respect to each such investment the securities held by the Executive do not exceed five
percent (5%) of the outstanding securities of such Person and such securities are publicly traded
and registered under Section 12 of the Securities Exchange Act of 1934, as amended (the
“Exchange Act”); and (ii) the Executive may serve on the board of directors (or other
comparable position) or as an officer of any entity at the request of the Board; provided,
however, that in the case of investments otherwise permitted under clause (i) above, the
Executive shall not be permitted to, directly or indirectly, participate in, or attempt to
influence, the management, direction or policies of (other than through the exercise of any voting
rights held by the Executive in connection with such securities), or lend the Executive’s name to,
any such Person.



               (d) The Executive acknowledges and agrees that, for purposes of this Section 5.3, indirect
acts by the Executive shall include, without limitation, an act by the Executive’s spouse,
ancestor, lineal descendant, lineal descendant’s spouse, sibling or other member of the Executive’s
immediate family.



               (e) the Executive acknowledges that (i) the restrictive covenants contained in this Section
5.3 hereof are ancillary to and part of an otherwise enforceable agreement, such being the
agreements concerning Confidential Information and other consideration as stated in this Agreement,
(ii) at the time that these restrictive covenants are made, the limitations as to time, geographic
scope and activity to be restrained, as described herein, are reasonable and do not impose a
greater restraint than necessary to protect the good



14









 




will and other legitimate business interests of the Company, including without limitation,
Confidential Information (including trade secrets), relationships with existing and prospective
customers, customer goodwill and business productivity, (iii) in the event of termination of the
Executive’s employment, the Executive’s experiences and capabilities are such that the Executive
can obtain gainful employment without violating this Agreement and without the Executive incurring
undue hardship, and (iv) based on the benefits stated in Sections 3 and 5.1 hereof and other new
consideration as recited in Section 5.3(a) hereof, including, without limitation, the disclosure
and use of Confidential Information, the restrictive covenants of this Section 5.3, as applicable
according to their terms, shall remain in full force and effect even in the event of the
Executive’s involuntary termination from employment, with or without Cause.




          5.4 Definitions. For purposes of this Agreement, the following terms shall have the
following meanings:




               (a) An “Affiliate” of any specified Person means any other Person, whether now or
hereafter existing, directly or indirectly controlling or controlled by, or under direct or
indirect common control with, such specified Person. For purposes hereof, “control” or any other
form thereof, when used with respect to any Person, means the power to direct the management and
policies of such Person, directly or indirectly, whether through the ownership of voting
securities, by contract or otherwise; and the terms “controlling” and “controlled” shall have
meanings correlative to the foregoing.



               (b) “Company Parties” means the Company, and its direct and indirect parents,
subsidiaries and Affiliates, and their successors in interest.



               (c) “Competing Business” means any business that competes with any of the Company
Parties, including, without limitation, any enterprise that engages in, owns or operates businesses
that market, sell, distribute, manufacture or otherwise are involved in the nutritional supplements
industry.



               (d) Confidential Information.




               (i) Definition. “Confidential Information” means any and all
material, information, ideas, inventions, formulae, patterns, compilations,
programs, devices, methods, techniques, processes, know how, plans (marketing,
business, strategic, technical or otherwise), arrangements, pricing and other data
of or relating to any of the Company Parties (as well as their customers and/or
vendors) that is confidential, proprietary or trade secret (A) by its nature, (B)
based on how it is treated or designated by a Company Party, (C) because the
disclosure of which would have a material adverse effect on the business or planned
business of any of the Company Parties and/or (D) as a matter of law.




               (ii) Exclusions. Confidential Information does not include material,
data, and/or information (A) that any Company Party has voluntarily placed in the
public domain, (B) that has been lawfully and independently developed and publicly
disclosed by third parties, (C) that constitutes the general non-specialized
knowledge and skills gained by the



15









 







Executive during the Employment Period or (D) that otherwise enters the public
domain through lawful means; provided, however, that the
unauthorized appropriation, use or disclosure of Confidential Information by the
Executive, directly or indirectly, shall not affect the protection and relief
afforded by this Agreement regarding such information.




               (iii) Inclusions. Confidential Information includes, without
limitation, the following information (including without limitation, compilations or
collections of information) relating or belonging to any Company Party (as well as
their customers and/or vendors) and created, prepared, accessed, used or reviewed by
the Executive during or after the Employment Period: (1) product and manufacturing
information, such as ingredients, combinations of ingredients and manufacturing
processes; (2) scientific and technical information, such as research and
development, tests and test results, formulas and formulations and studies and
analysis; (3) financial and cost information, such as operating and production
costs, costs of goods sold, costs of supplies and manufacturing materials,
non-public financial statements and reports, profit and loss information, margin
information and financial performance information; (4) customer related information,
such as customer related contracts, engagement and scope of work letters, proposals
and presentations, customer related contacts, lists, identities, and prospects,
customer practices, plans, histories, requirements and needs, customer related price
information and formulae and information obtained from customers concerning their
products, businesses or equipment specifications; (5) vendor and supplier related
information, such as the identities, practices, history or services of any vendors
or suppliers and vendor or supplier contacts; (6) sales, marketing and price
information, such as marketing and sales programs and related data, sales and
marketing strategies and plans, sales and marketing procedures and processes,
pricing methods, practices and techniques and pricing schedules and lists; (7)
database, software, and other computer related information, such as computer
programs, data, compilations of information and records, software and computer
files, presentation software and computer-stored or backed-up information including
e-mails, databases, word processed documents, spreadsheets, notes, schedules, task
lists, images and video; (8) employee-related information, such as lists or
directories identifying employees, representatives and contractors, and information
regarding the competencies (knowledge, skill, experience), compensation and needs of
employees, representatives and contractors and training methods; and (9) business-
and operation-related information, such as operating methods, procedures,
techniques, practices and processes, information about acquisitions, corporate or
business opportunities, information about partners and potential investors,
strategies, projections and related documents, contracts and licenses and business
records, files, equipment, notebooks, documents, memoranda, reports, notes, sample
books, correspondence, lists and other written and graphic business records.



16









 





               (e) “Misappropriate”, or any form thereof, means:




               (i) the acquisition of any Confidential Information by a Person who knows or
has reason to know that the Confidential Information was acquired by theft, bribery,
misrepresentation, breach or inducement of a breach of a duty to maintain secrecy,
or espionage through electronic or other means (each, an “Improper Means”);
or




               (ii) the disclosure or use of any Confidential Information without the express
consent of the Company by a Person who (A) used Improper Means to acquire knowledge
of the Confidential Information; or (B) at the time of disclosure or use, knew or
had reason to know that his or her knowledge of the Confidential Information was (x)
derived from or through a Person who had utilized Improper Means to acquire it, (y)
acquired under circumstances giving rise to a duty to maintain its secrecy or limit
its use, or (z) derived from or through a Person who owed a duty to the Company to
maintain its secrecy or limit its use; or (C) before a material change of his or her
position, knew or had reason to know that it was a Confidential Information and that
knowledge of it had been acquired by accident or mistake.



               (f) “Person” means any individual, corporation, partnership, limited liability
company, joint venture, association, business trust, joint-stock company, estate, trust,
unincorporated organization, government or other agency or political subdivision thereof or any
other legal or commercial entity.



               (g) “Restricted Period” means the longer of (i) twelve (12) months after the date of
termination of employment (the Executive’s last day of work for the Company) or (ii) the period
during which the Executive is receiving payments from the Company pursuant to Section 4 hereof.



               (h) “Work Product” means all patents and patent applications, all inventions,
innovations, improvements, developments, methods, designs, analyses, drawings, reports, creative
works, discoveries, software, computer programs, modifications, enhancements, know-how,
formulations, concepts and ideas, and all similar or related information (in each case whether or
not patentable), all copyrights and copyrightable works, all trade secrets, confidential
information, and all other intellectual property and intellectual property rights that are
conceived, reduced to practice, developed or made by the Executive either alone or with others in
the course of employment with the Company (including employment prior to the date of this
Agreement).



          5.5 Remedies. Because the Executive’s services are unique and because the Executive
has access to Confidential Information, the Executive acknowledges and agrees that if the Executive
breaches any of the provisions of Section 5 hereof, the Company may suffer immediate and
irreparable harm for which monetary damages alone will not be a sufficient remedy. The restrictive
covenants stated in Section 5 hereof are without prejudice to the Company’s rights and causes of
action at law.




17









 








          5.6 Interpretation; Severability.




               (a) The Executive has carefully considered the possible effects on the Executive of the
covenants not to compete, the confidentiality provisions and the other obligations contained in
this Agreement, and the Executive recognizes that the Company has made every effort to limit the
restrictions placed upon the Executive to those that are reasonable and necessary to protect the
Company’s legitimate business interests.



               (b) The Executive acknowledges and agrees that the restrictive covenants set forth in this
Agreement are reasonable and necessary in order to protect the Company’s valid business interests.
It is the intention of the parties hereto that the covenants, provisions and agreements contained
herein shall be enforceable to the fullest extent allowed by law. If any covenant, provision or
agreement contained herein is found by a court having jurisdiction to be unreasonable in duration,
scope or character of restrictions, or otherwise to be unenforceable, such covenant, provision or
agreement shall not be rendered unenforceable thereby, but rather the duration, scope or character
of restrictions of such covenant, provision or agreement shall be deemed reduced or modified with
retroactive effect to render such covenant, provision or agreement reasonable or otherwise
enforceable (as the case may be), and such covenant, provision or agreement shall be enforced as
modified. If the court having jurisdiction will not review the covenant, provision or agreement,
the parties hereto shall mutually agree to a revision having an effect as close as permitted by
applicable law to the provision declared unenforceable. The parties hereto agree that if a court
having jurisdiction determines, despite the express intent of the parties hereto, that any portion
of the covenants, provisions or agreements contained herein are not enforceable, the remaining
covenants, provisions and agreements herein shall be valid and enforceable. Moreover, to the
extent that any provision is declared unenforceable, the Company shall have any and all rights
under applicable statutes or common law to enforce its rights with respect to any and all
Confidential Information or unfair competition by the Executive.



     6. Miscellaneous.



          6.1 Public Statements.




               (a) Media Nondisclosure. The Executive agrees that during the Employment Period or at
any time thereafter, except as may be authorized in writing by the Company, the Executive will not
directly or indirectly disclose or release to the Media any information concerning or relating to
any aspect of the Executive’s employment or termination from employment with the Company and/or any
aspect of any dispute that is the subject of this Agreement. For the purposes of this Agreement,
the term “Media” includes, without limitation, any news organization, station, publication,
show, website, web log (blog), bulletin board, chat room and/or program (past, present and/or
future), whether published through the means of print, radio, television and/or the Internet or
otherwise, and any member, representative, agent and/or employee of the same.



               (b) Non-Disparagement. The Executive agrees that during the Employment Period or at
any time thereafter, the Executive will not make any statements, comments or communications in any
form, oral, written or electronic to any Media or any



18









 




customer, client or supplier of the Company or any of its Affiliates, which would constitute
libel, slander or disparagement of the Company or any of its Affiliates, including, without
limitation, any such statements, comments or communications that criticize, ridicule or are
derogatory to the Company or any of its Affiliates; provided, however, that the
terms of this Section 6.1(b) shall not apply to communications between the Executive and, as
applicable, the Executive’s attorneys or other persons with whom communications would be subject to
a claim of privilege existing under common law, statute or rule of procedure. The Executive
further agrees that the Executive will not in any way solicit any such statements, comments or
communications from others.




          6.2 ARBITRATION. SUBJECT TO THE RIGHTS UNDER SECTION 6.3 HEREOF TO SEEK INJUNCTIVE OR
OTHER EQUITABLE RELIEF, BINDING ARBITRATION SHALL BE THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES,
CLAIMS, OR CONTROVERSIES, WHETHER STATUTORY, CONTRACTUAL OR OTHERWISE, BETWEEN THE PARTIES HERETO
ARISING UNDER OR RELATING TO THIS AGREEMENT OR THE EXECUTIVE’S EMPLOYMENT BY OR TERMINATION FROM
THE COMPANY (INCLUDING, BUT NOT LIMITED TO, THE AMOUNT OF DAMAGES, OR THE CALCULATION OF ANY BONUS
OR OTHER AMOUNT OR BENEFIT DUE) (COLLECTIVELY, “DISPUTES”). THE PARTIES EACH WAIVE THE
RIGHT TO A JURY TRIAL AND WAIVE THE RIGHT TO ADJUDICATE THEIR DISPUTES UNDER THIS AGREEMENT OUTSIDE
THE ARBITRATION FORUM PROVIDED FOR IN THIS AGREEMENT, EXCEPT AS OTHERWISE PROVIDED IN THIS
AGREEMENT. In the event either party provides a notice of arbitration of any dispute to the other
party, the parties agree to submit that dispute to a single arbitrator selected from a panel of
arbitrators of JAMS located in Pittsburgh, Pennsylvania. The arbitration will be governed by the
JAMS Comprehensive Arbitration Rules and Procedures in effect at the time the arbitration is
commenced. If for any reason JAMS cannot serve as the arbitration administrator, the Company may
select an alternative arbitration administrator such as the American Arbitration Association, to
serve under the terms of this Agreement.




               (a) VENUE. THE PARTIES STIPULATE AND AGREE THAT THE EXCLUSIVE VENUE OF ANY SUCH
ARBITRATION PROCEEDING (AND OF ANY OTHER PROCEEDING, INCLUDING ANY COURT PROCEEDING, UNDER THIS
AGREEMENT) SHALL BE ALLEGHENY COUNTY, PENNSYLVANIA (THE “AGREED VENUE”).



               (b) Authority and Decision. The arbitrator shall have the authority to award the same
damages and other relief that a court could award. The arbitrator shall issue a reasoned award
explaining the decision and any damages awarded. The arbitrator’s decision will be final and
binding upon the parties and enforceable by a court of competent jurisdiction. The parties will
abide by and perform any award rendered by the arbitrator. In rendering the award, the arbitrator
shall state the reasons therefor, including (without limitation) any computations of actual damages
or offsets, if applicable.



               (c) Fees and Costs. In the event of arbitration under the terms of this Agreement,
the fees charged by JAMS or other arbitration administrator and the arbitrator shall be borne by
the parties as determined by the arbitrator, except for any initial registration



19









 




fee, which the parties shall bear equally. Otherwise, the parties shall each bear their own
costs, expenses and attorneys’ fees incurred in arbitration; provided, however,
that the prevailing party shall be entitled to recover and have awarded its attorneys’ fees, court
costs, arbitration expenses, and its portion of the fees and costs charged by JAMS or other
arbitration administrator, regardless of which party initiated the proceedings, in addition to any
other relief to which it may be entitled.




               (d) Limited Scope. The following are excluded from binding arbitration under this
Agreement: claims for workers’ compensation benefits or unemployment benefits; replevin; and
claims for which a binding arbitration agreement is invalid as a matter of law.



          6.3 Injunctive Relief. The parties hereto may seek injunctive relief in arbitration;
provided, however, that as an exception to the arbitration agreement set forth
Section 6.2 hereof, the parties, in addition to all other available remedies, shall each have the
right to initiate an action in any court of competent jurisdiction in order to request injunctive
or other equitable relief regarding the terms of Sections 5 or 6.2 hereof. The exclusive venue of
any such proceeding shall be in the Agreed Venue. The parties agree (a) to submit to the
jurisdiction of any competent court in the Agreed Venue, (b) to waive any and all defenses the
Executive may have on the grounds of lack of jurisdiction of such court and (c) that neither party
shall be required to post any bond, undertaking or other financial deposit or guarantee in seeking
or obtaining such equitable relief. Evidence adduced in any such proceeding for an injunction may
be used in arbitration as well. The existence of this right shall not preclude or otherwise limit
the applicability or exercise of any other rights and remedies that a party hereto may have at law
or in equity.




          6.4 Settlement of Existing Rights. In exchange for the other terms of this Agreement,
the Executive acknowledges and agrees that: (a) the Executive’s entry into this Agreement is a
condition of employment and/or continued employment with the Company, as applicable; (b) except as
otherwise provided herein, this Agreement will replace any existing employment agreement between
the parties and thereby act as a novation, if applicable; (c) the Executive is being provided with
access to Confidential Information, including, without limitation, proprietary trade secrets of one
or more Company Parties, to which the Executive has not previously had access; (d) all Company
inventions and intellectual property developed by the Executive during any past employment with the
Company and all goodwill developed with the Company’s clients, customers and other business
contacts by the Executive during any past employment with Company, as applicable, is the exclusive
property of the Company; and (e) all Confidential Information and/or specialized training accessed,
created, received or utilized by the Executive during any past employment with Company, as
applicable, will be subject to the restrictions on Confidential Information described in this
Agreement, whether previously so agreed or not.




          6.5 Entire Agreement; Waiver. This Agreement contains the entire agreement between
the Executive and the Company with respect to the subject matter hereof, and supersedes any and all
prior understandings or agreements, whether written or oral. No modification or addition hereto or
waiver or cancellation of any provision hereof shall be valid except by a writing signed by the
party to be charged therewith. No delay on the part of any

20









 








party to this Agreement in exercising any right or privilege provided hereunder or by law
shall impair, prejudice or constitute a waiver of such right or privilege.




          6.6 Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the Commonwealth of Pennsylvania, without regard to principles of conflict of
laws.




          6.7 Successors and Assigns; Binding Agreement. The rights and obligations of the
parties under this Agreement shall be binding upon and inure to the benefit of the parties hereto
and their heirs, personal representatives, successors and permitted assigns. This Agreement is a
personal contract, and, except as specifically set forth herein, the rights and interests of the
Executive herein may not be sold, transferred, assigned, pledged or hypothecated by any party
without the prior written consent of the others. As used herein, the term “successor” as it
relates to the Company, shall include, but not be limited to, any successor by way of merger,
consolidation, or sale of all or substantially all of such Person’s assets or equity interests.




          6.8 Representation by Counsel; Independent Judgment. Each of the parties hereto
acknowledges that (a) it or the Executive has read this Agreement in its entirety and understands
all of its terms and conditions, (b) it or the Executive has had the opportunity to consult with
any individuals of its or the Executive’s choice regarding its or the Executive’s agreement to the
provisions contained herein, including legal counsel of its or the Executive’s choice, and any
decision not to was the Executive’s or its alone, and (c) it or the Executive is entering into this
Agreement of its or the Executive’s own free will, without coercion from any source, based upon its
or the Executive’s own independent judgment.




          6.9 Interpretation. The parties and their respective legal counsel actively
participated in the negotiation and drafting of this Agreement, and in the event of any ambiguity
or mistake herein, or any dispute among the parties with respect to the provisions hereto, no
provision of this Agreement shall be construed unfavorably against any of the parties on the ground
that the Executive, it, or the Executive’s or its counsel was the drafter thereof.




          6.10 Survival. The provisions of Sections 4.3(e), 5 and 6 hereof shall survive the
termination of this Agreement.




          6.11 Notices. All notices and communications hereunder shall be in writing and shall
be deemed properly given and effective when received, if sent by facsimile or telecopy, or by
postage prepaid by registered or certified mail, return receipt requested, or by other delivery
service which provides evidence of delivery, as follows:



If to the Company, to:



General Nutrition Centers, Inc.

300 Sixth Avenue

Pittsburgh, PA 15222

Attention: General Counsel




21









 




with a copy (which shall not constitute notice) to:



Gardere Wynne Sewell LLP

1601 Elm Street, Suite 3000

Dallas, Texas 75201-4761

Attention: Ronald M. Gaswirth, Esq.

Telephone: (214) 999-4601

Facsimile: (214) 999-3601

E-mail: rgaswirth@gardere.com



If to the Executive, to:



Robert Homler

c/o General Nutrition Centers, Inc.

300 Sixth Avenue

Pittsburgh, Pennsylvania 15222



or to such other address as one party may provide in writing to the other party from time to time.




          6.12 Counterparts. This Agreement may be executed in one or more counterparts, each
of which shall be deemed an original and all of which together shall constitute one and the same
instrument. Facsimile transmission of any signed original document or retransmission of any signed
facsimile transmission will be deemed the same as delivery of an original. At the request of any
party, the parties will confirm facsimile transmission by signing a duplicate original document.




          6.13 Captions. Paragraph headings are for convenience only and shall not be
considered a part of this Agreement.




          6.14 No Third Party Beneficiary Rights. Except as otherwise provided in this
Agreement, no entity shall have any right to enforce any provision of this Agreement, even if
indirectly benefited by it.




          6.15 Withholding. Any payments provided for hereunder shall be paid net of any
applicable withholding required under Federal, state or local law and any additional withholding to
which Executive has agreed.




[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]




22









 





     IN WITNESS WHEREOF, the parties have duly executed this Agreement, intending it as a document
under seal, on the Execution Date to be effective for all purposes as of the Effective Date.



	 	 	 	 	 	 	 	 	 
	WITNESS/
	 	 	 	 	 	 	 	 
	ATTEST:	 	 	 	GENERAL NUTRITION CENTERS, INC.
	 
	 	 	 	 	 	 	 	 
	     /s/ Ron Gaswirth

	 	 	 	By:
	 	     /s/ Robert J. DiNicola	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name: Robert J. DiNicola	 	 
	 

	 	 	 	 	 	Title: Chairman of the Board	 	 
	 
	 	 	 	 	 	 	 	 
	     /s/ Ron Gaswirth

	 	 	 	By:
	 	     /s/ Joseph Fortunato	 	 
	 

	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name: Joseph Fortunato	 	 
	 

	 	 	 	 	 	Title: President and Chief Executive Officer	 	 
	 
	 	 	 	 	 	 	 	 
	 	 	 	 	EXECUTIVE	 	 
	 
	 	 	 	 	 	 	 	 
	     /s/ Ron Gaswirth	 	 	 	               /s/ Robert Homler	 	 
	 	 	 	 	 	 	 
	 	 	 	 	Name: Robert Homler	 	 







 









 









EXHIBIT A




Definition of Change of Control




     “Change of Control” means:



     (1) any event occurs the result of which is that any “Person,” as such term is used in
Sections 13(d) and 14(d) of the Exchange Act, other than one or more Permitted Holders or their
Related Parties, becomes the beneficial owner, as defined in Rules l3d-3 and l3d-5 under the
Exchange Act (except that a Person shall be deemed to have “beneficial ownership” of all shares
that any such Person has the right to acquire within one year) directly or indirectly, of more than
50% of the Voting Stock of GNC or any successor company, including, without limitation, through a
merger or consolidation or purchase of Voting Stock of GNC; provided that the Permitted Holders or
their Related Parties do not have the right or ability by voting power, contract or otherwise to
elect or designate for election a majority of the GNC Board of Directors; provided further that the
transfer of 100% of the Voting Stock of GNC to a Person that has an ownership structure identical
to that of GNC prior to such transfer, such that GNC becomes a wholly owned Subsidiary of such
Person, shall not be treated as a Change of Control for purposes of the indenture;



     (2) after an initial public offering of Capital Stock of GNC, during any period of two (2)
consecutive years, individuals who at the beginning of such period constituted the GNC Board of
Directors, together with any new directors whose election by such GNC Board of Directors or whose
nomination for election by the stockholders of GNC was approved by a vote of a majority of the
directors of GNC then still in office who were either directors at the beginning of such period or
whose election or nomination for election was previously so approved, cease for any reason to
constitute a majority of the GNC Board of Directors then in office;



     (3) the sale, lease, transfer, conveyance or other disposition, in one or a series of related
transactions other than a merger or consolidation, of all or substantially all of the assets of GNC
and its Subsidiaries taken as a whole to any Person or group of related Persons other than a
Permitted Holder or a Related Party of a Permitted Holder; or



     (4) the adoption of a plan relating to the liquidation or dissolution of GNC.



     For purposes of this definition, the following terms shall have the meanings set forth below:



     An “Affiliate” of any specified Person means any other Person, whether now or hereafter
existing, directly or indirectly controlling or controlled by, or under direct or indirect common
control with, such specified Person. For purposes hereof, “control” or any other form thereof,
when used with respect to any Person, means the power to direct the management and policies of such
Person, directly or indirectly, whether through the ownership of voting securities, by contract or
otherwise; and the terms “controlling” and “controlled” shall have meanings correlative to the
foregoing.



     “Apollo” means Apollo Management V, L.P. and its Affiliates or any entity controlled



A-1









 







thereby or any of the partners thereof.



     “Capital Stock” of any Person means any and all shares, interests, rights to purchase,
warrants, options, participations or other equivalents of or interests in, however designated,
equity of such Person, including any Preferred Stock, but excluding any debt securities convertible
into such equity.



     “Exchange Act” means the Securities Exchange Act of 1934, as amended.



     “GNC” means GNC Corporation, a Delaware corporation.



     “GNC Board of Directors” means the Board of Directors of GNC or any committee thereof duly
authorized to act on behalf of such Board of Directors.



     “Permitted Holder” means Apollo.



     “Person” means any individual, corporation, partnership, limited liability company, joint
venture, association, business trust, joint-stock company, estate, trust, unincorporated
organization, government or other agency or political subdivision thereof or any other legal or
commercial entity.



     “Preferred Stock” as applied to the Capital Stock of any corporation means Capital Stock of
any class or classes, however designated, that is preferred as to the payment of dividends, or as
to the distribution of assets upon any voluntary or involuntary liquidation or dissolution of such
corporation, over shares of Capital Stock of any other class of such corporation.



     “Related Party” means:




     (1) any controlling stockholder, 80% (or more) owned Subsidiary, or immediate family
member (in the case of an individual) of any Permitted Holder; or




     (2) any trust, corporation, partnership, limited liability company or other entity, the
beneficiaries, stockholders, partners, members, owners or Persons beneficially holding an
80% or more controlling interest of which consist of any one or more Permitted Holders
and/or such other Persons referred to in the immediately preceding clause (1).



     “Subsidiary” means, with respect to any specified Person:




     (1) any corporation, association or other business entity of which more than 50% of the
total voting power of shares of Capital Stock entitled (without regard to the occurrence of
any contingency and after giving effect to any voting agreement or stockholders’ agreement
that effectively transfers voting power) to vote in the election of directors, managers or
trustees of the corporation, association or other business entity is at the time owned or
controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries
of that Person (or a combination thereof); and



A-2




 









 






     (2) any partnership (a) the sole general partner or the managing general partner of
which is such Person or a Subsidiary of such Person or (b) the only general partners of
which are that Person or one or more Subsidiaries of that Person (or any combination
thereof).



     “Voting Stock” of an entity means all classes of Capital Stock of such entity then outstanding
and normally entitled to vote in the election of directors or all interests in such entity with the
ability to control the management or actions of such entity.



     Notwithstanding anything to the contrary in this Exhibit A, the definition of Change of
Control shall be interpreted consistently with the definition of “Change of Control” contained in
Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and regulations
and guidance issued by the Internal Revenue Service under Section 409A of the Code, including IRS
Notice 2005-1.



A-3




 









 








EXHIBIT B




Fringe Benefits





	1.	 	Health insurance in accordance with the Company’s health insurance plan or program in
effect from time to time.
	 
	2.	 	Prescription drug coverage in accordance with the Company’s health insurance plan or
program, or separate prescription drug coverage plan or program, in effect from time to
time.
	 
	3.	 	Dental insurance in accordance with the Company’s dental insurance plan or program in
effect from time to time.
	 
	4.	 	Long-term disability insurance in accordance with the Company’s long-term disability
insurance plan or program in effect from time to time.
	 
	5.	 	Short-term disability insurance in accordance with the Company’s short-term insurance
plan or program in effect from time to time.
	 
	6.	 	Life insurance coverage in amount equal to one (1) times Base Salary.
	 
	7.	 	Automobile allowance in an annual amount equal to $11,500, which shall be paid in 26
equal bi-weekly installments each year in accordance with the Company’s normal payroll
practices and procedures in effect from time to time.
	 
	8.	 	Professional Assistance with an annual value in an amount equal to $10,500, which shall
be paid in 26 equal bi-weekly installments each year in accordance with the Company’s
normal payroll practices and procedures in effect from time to time.
	 
	9.	 	A supplemental retirement allowance in an annual amount equal to $10,000, which shall
be paid in 26 equal bi-weekly installments each year in accordance with the Company’s
normal payroll practices and procedures in effect from time to time.
	 
	10.	 	A financial planning and tax preparation allowance in an amount equal to $8,000 per
year, which shall be paid in 26 equal bi-weekly installments each year in accordance with
the Company’s normal payroll practices and procedures in effect from time to time.
	 
	11.	 	A downtown Pittsburgh parking lease with an annual value in an amount equal to $3,300.
	 
	12.	 	An executive medical allowance in an annual amount equal to $6,000, which shall be paid
in 26 equal bi-weekly installments each year in accordance with the Company’s normal
payroll practices and procedures in effect from time to time.





B-1